DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.
��/p>
Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.
Read More: 5 Breakout Stocks to Trade for Gains
��/p>
Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.
Hot Cheap Stocks To Own For 2015: Endesa SA (ELE.MC)
Endesa SA is a Spain-based holding company engaged in the energy sector. The Company is primarily involved in the generation, distribution and supply of energy from different sources, such as gas, cogeneration and renewables. It also generates, distributes and supplies electricity. The Company is also engaged in real estate operations as well as coal mining. Its business is divided into four lines: Electricity, Gas, Cogeneration and renewables; as well Other activities. The Company operates in such countries as Spain, Portugal, Chile, Brazil, Colombia, Peru, Argentina, Morocco and China, among others. The Company operates a number of subsidiaries worldwide. The Company is a member of Enel Group. Advisors' Opinion:- [By Anna Prior]
Cheniere Energy Inc.(LNG) said Spanish energy company Endesa SA(ELE.MC) agreed to purchase about 1.5 million tons a year of liquified natural gas from the Houston-based company’s planned Corpus Christi export operations. The agreement is for 20 years from the first commercial delivery, which is expected to start as soon as 2018. Shares edged up 2.4% to $58.99 premarket.
Top 10 Forestry Stocks To Watch For 2014: Brown-Forman Corp (BF.B)
Brown-Forman Corporation, incorporated on October 19, 1933, primarily manufactures, bottles, imports, exports, markets, and sells a variety of alcoholic beverage brands. The Company�� principal brands are Jack Daniel�� Tennessee Whiskey, Jack Daniel�� Tennessee Whiskey, Pepe Lopez Tequilas, Jack Daniel�� Single Barrel, Woodford Reserve Bourbons, Jack Daniel�� Ready-to-Drinks, Canadian Mist Blended Canadian Whiskies, Jack Daniel�� Tennessee Honey, Chambord Liqueur, Jack Daniel�� Winter Jack Chambord Vodka, Gentleman Jack, Collingwood Canadian Whisky, Southern Comfort, Early Times Bourbon, Southern Comfort Ready-to-Drinks, Early Times flavored line extensions, Southern Comfort flavored line extensions, Early Times Kentucky Whisky, Finlandia Vodkas, Korbel California Champagnes, Finlandia Ready-to-Drinks, Little Black Dress Vodkas, Antiguo Tequila, Maximus Vodkas, el Jimador Tequilas, Old Forester Bourbon, el Jimador New Mix Ready-to-Drinks, Sonoma-Cutrer Wines, Herradura Tequilas, and Tuaca Liqueur.
The Company�� products are sold in more than 150 countries around the world. The Company�� international markets include Australia, the United Kingdom, Mexico, Germany, Poland, France, Russia, Japan, Turkey, Canada, Spain, Czech Republic, South Africa, Brazil and Italy.
The Company competes with Bacardi Limited, Beam Inc., Davide Campari-Milano S.p.A., Diageo plc, LVMH Moet Hennessy Louis Vuitton S.A., Pernod Ricard S.A., and Remy Cointreau S.A.
Advisors' Opinion:- [By Sue Chang and Saumya Vaishampayan]
BFB: Brown-Forman Corp. (BF.B) �Class B shares gained 3.7%. The alcoholic beverage maker reported fiscal third-quarter earnings Wednesday that beat expectations and boosted its full-year view on per-share earnings to between $2.95 and $3.05.
Top 10 Forestry Stocks To Watch For 2014: Marin Software Inc (MRIN)
Marin Software Incorporated, incorporated on March 16, 2006, provides cloud-based digital advertising management platform to advertisers and agencies. The Company�� Revenue Acquisition Management platform is a software-as-a-service (SaaS), analytics, workflow, and optimization solution for marketing professionals, enabling them to manage their digital advertising spend across search, display, social and mobile advertising channels. Its platform integrates with publishers, such as Baidu, Bing, Facebook, Google, Yahoo! and Yahoo! Japan, as well as Web analytics and ad-serving solutions, and key enterprise applications to enable marketers to measure the return on investment of their marketing programs.
The Company�� software platform serves as a system-of-record for advertising performance, revenue and conversion data and allows advertisers to correlate advertising spend to subsequent revenue outcomes or business events. It enables its customers to simultaneously run large-scale digital advertising campaigns across multiple publishers and channels, making it easy for marketers to create, publish, modify and optimize campaigns in real time.
Advisors' Opinion:- [By Evan Niu, CFA]
What: Shares of Marin Software (NYSE: MRIN ) got clobbered today, down by as much as 21% after the company reported earnings.
So what: Revenue in the first quarter totaled $17.2 million, which resulted in a non-GAAP net loss of $9.4 million, or $0.39 per share. The freshly public software maker saw gross margin decline to 57%, and its losses grew from a year ago. Investors obviously wanted more.
Top 10 Forestry Stocks To Watch For 2014: ING Groep NV (INGA)
ING Groep N.V. (ING) is a global financial institution offering banking, investments, life insurance and retirement services to meet the needs of the customers. The Company�� segments include banking and insurance. Banking segment includes retail Netherlands, retail Belgium, ING direct, retail central Europe (CE), retail Asia, commercial banking (excluding real estate), ING real estate and corporate line banking. Insurance segment includes insurance Benelux, insurance central and rest of Europe (CRE), insurance United States (US), Insurance US closed block VA, insurance Asia/Pacific, ING investment management (IM) and corporate line insurance. In November 2013, the Company completed the sale of ING Hipotecaria to Banco Santander (Mexico), S.A. In December 2013, the Company completed the sale of its 33.3% interest in China Merchants Fund to its joint venture partners China Merchants Bank Co Ltd and China Merchants Securities Co Ltd, and divested ING Life Korea to MBK Partners. Advisors' Opinion:- [By Sofia Horta e Costa]
ING (INGA), which received a 10 billion-euro government bailout in 2008, gained 5.1 percent to 8.26 euros. Underlying pretax profit for the banking unit rose 14 percent to 1.15 billion euros in the second quarter as the interest margin improved and cost cuts paid off, the biggest Dutch financial-services company said.
Top 10 Forestry Stocks To Watch For 2014: Covidien PLC (COV)
Covidien Public Limited Company is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. It operates its businesses through three segments: Medical Devices, which includes the development, manufacture and sale of endomechanical instruments, energy devices, soft tissue repair products, vascular products, oximetry and monitoring products, airway and ventilation products; Pharmaceuticals, which includes the development, manufacture and distribution of specialty pharmaceuticals and active pharmaceutical ingredients, and Medical Supplies, SharpSafety products and original equipment manufacturer products. In May 2012, it acquired Newport Medical Instruments, Inc. In May 2012, it acquired superDimension, Ltd. In June 2012, the Company acquired Oridion Systems Ltd. In October 2012, its Mallinckrodt acquired CNS Therapeutics, Inc. In January 2013, the Company acquired CV Ingenuity. Advisors' Opinion:- [By Ben Levisohn]
Intuitive Surgical has gained 4.3% to $397.20 today, easily trumping the gains in other healthcare-equipment companies. �Covidien�(COV) has ticked down 0.3% to $60.08, Medtronic�(MDT) has gained 0.5% to $52.97, Abbott Laboratories�(ABT) has fallen 0.8% to $33.24, and C.R. Bard (BCR) is little changed at $114.52.
- [By Garrett Cook]
Shares of Covidien plc (NYSE: COV) got a boost, shooting up 21.08 percent to $87.20 after Medtronic (NYSE: MDT) announced its plans to buy Covidien for $42.9 billion in cash and stock.
Top 10 Forestry Stocks To Watch For 2014: NeuroMetrix Inc.(NURO)
NeuroMetrix, Inc., a science-based health care company, develops and markets products for the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, such as those associated with diabetes, carpal tunnel syndrome, lumbosacral disc disease, and spinal stenosis. The company focuses on diagnosis and treatment of the neurological complications of diabetes, including diabetic peripheral neuropathy (DPN) and median neuropathy. Its marketed products include the ADVANCE NCS/EMG system, a platform for the performance of traditional nerve conduction studies and invasive electromyography procedures for the diagnosis and evaluation of CTS, low back and leg pain, and DPN; and the NC-stat DPNCheck, a device used to evaluate systemic neuropathies, such as DPN at the point-of-care, as well as consumables and accessories for use with its neurodiagnostic equipment. The company is also developing SENSUS pain therapy device, a transcutaneous electrical nerve stimul ator used in the management of chronic pain, such as that caused by DPN; and ADVANCE CTS, a version of the ADVANCE NCS/EMG device for the detection of CTS in people with diabetes. The company distributes its products directly through its direct sales force and independent sales representatives to physicians, clinics, and hospitals consisting of primary care, internal medicine, orthopedic and hand surgeons, pain medicine physicians, neurologists, physical medicine and rehabilitation, physicians, and neurosurgeons, as well as endocrinology/podiatry market in the United States and internationally. NeuroMetrix, Inc. was founded in 1996 and is headquartered in Waltham, Massachusetts.
Advisors' Opinion:- [By Bryan Murphy]
Don't get me wrong - it's fun to be right. There's such a thing as being too right (or at least too right, too fast) though, and when that happens, the smart thing to do is, well do something about it. Case in point? I was right yesterday about Neurometrix Inc. (NASDAQ:NURO). I suggested the stock was already in the midst of a breakout, and NURO was poised to soar. I didn't count on this morning's big jump and subsequent gap, however, so now that my risk of continuing to hold it is as big as my potential reward from here, I and anybody else who followed my lead has a tough decision to make... though I've already made mine.
Top 10 Forestry Stocks To Watch For 2014: CollabRx Inc (CLRX)
CollabRx, Inc., incorporated on September 20, 1995, is focused on developing and delivering content knowledge-based products and services that inform healthcare decision-making, with an emphasis on genomics-based precision medicine and big data analytics. The Company delivers content to users through Web-based applications and services in the cloud serving physicians and their patients in two settings: at the point-of-care in the clinic and indirectly, as a part of a genetic test report provided to an ordering physician by a diagnostic testing laboratory, (lab). The Company�� Therapy Finder Web-based application serves as an initial user-interface to the underlying knowledge base. It is available free of charge on its Website. In addition, a professional version is offered to registered physicians through MedPage Today, an offering of Everyday Health, Inc.
The Company�� offering provides the clinical interpretation of genetic variants present in human tumor biopsies, and is sold directly to diagnostic labs that perform molecular testing on patients. Its Genetic Variant Application (GVA) is compiled by its software platform to provide specific insights to a patient�� diagnostic test results on a test-by-test basis. The GVA results are provided to laboratories in a variety of forms, including with a front-end user Interface (UI) or directly integrated into a customer�� laboratory information management system (LIMS). The Company�� content is identified as Powered by CollabRx within the test report. Portions of its Web-based applications are available free to physicians and patients through commercial on-line media partners under a license and advertising or sponsorship revenue sharing arrangement. The content that, the Company offers to laboratories is sold based on a variation of Software as a service (SaaS) business model, in which its content is provided on a one-time, subscription or per test basis. It also receives fee-for-service payments in connection with customized user ! interfaces to its database.
Advisors' Opinion:- [By John Udovich]
Small cap healthcare information stocks Everyday Health Inc (NYSE: EVDY), Foundation Medicine Inc (NASDAQ: FMI) and CollabRx Inc (NASDAQ: CLRX) help consumers and healthcare professionals deal with the increasing amount of information overload that comes with treating or figuring out how to treat patients.
- [By Bryan Murphy]
They say you're known by the caliber of company you keep. If that's true for stocks (and it is), then CollabRx Inc. (NASDAQ:CLRX) has a lot to be proud of with its new partnership with Affymetrix, Inc. (NASDAQ:AFFX). On the flipside, Affymetrix should be honored it's inked a deal with CollabRx. In a combination that hasn't been topped since peanut butter and chocolate hooked up to form a Reese's cup, AFFX and CLRX help bring out the best in each other.
- [By James E. Brumley]
On the surface it's the kind of thing the market doesn't want to see. In reality though, CollabRx Inc. (NASDAQ:CLRX) will be far better off - and far batter positioned to reward shareholders - by doing what needs to be done in order to continue capitalizing on the opportunity it has in front of it. And what exactly did CLRX do? It raised some money by shares it had sitting on the shelf.
- [By Bryan Murphy]
Eat your heart out Foundation Medicine Inc. (NASDAQ:FMI). And WebMD Health Corp. (NASDAQ:WBMD)? Don't even bother trying. CollabRx Inc. (NASDAQ:CLRX) has built a better mousetrap, and if yesterday's announcement is a sign of things to come, CLRX could prove to be a very compelling investment.
No comments:
Post a Comment